Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Infant, Premature | 18 | 2020 | 817 | 1.730 |
Why?
|
Energy Metabolism | 21 | 2006 | 767 | 1.140 |
Why?
|
Enteral Nutrition | 6 | 2014 | 256 | 0.850 |
Why?
|
Sucking Behavior | 4 | 2012 | 21 | 0.840 |
Why?
|
Milk, Human | 22 | 2012 | 300 | 0.790 |
Why?
|
Adipose Tissue | 20 | 2006 | 467 | 0.760 |
Why?
|
Body Composition | 22 | 2005 | 522 | 0.720 |
Why?
|
Infant, Newborn | 71 | 2020 | 8162 | 0.710 |
Why?
|
Body Weight | 29 | 2014 | 990 | 0.700 |
Why?
|
Lactation | 13 | 2007 | 193 | 0.670 |
Why?
|
Obesity | 17 | 2014 | 2248 | 0.640 |
Why?
|
Breast Feeding | 20 | 2000 | 219 | 0.630 |
Why?
|
Swine | 11 | 2008 | 1210 | 0.600 |
Why?
|
Isoflavones | 4 | 2013 | 45 | 0.600 |
Why?
|
Feeding Behavior | 6 | 2012 | 701 | 0.570 |
Why?
|
Female | 167 | 2020 | 66570 | 0.570 |
Why?
|
Mothers | 1 | 2020 | 354 | 0.550 |
Why?
|
Stress, Psychological | 2 | 2020 | 558 | 0.530 |
Why?
|
Self Concept | 2 | 2016 | 155 | 0.530 |
Why?
|
Parenting | 1 | 2020 | 331 | 0.520 |
Why?
|
beta-Glucans | 3 | 2013 | 19 | 0.520 |
Why?
|
Minority Groups | 3 | 2016 | 248 | 0.500 |
Why?
|
Postpartum Period | 5 | 2003 | 214 | 0.480 |
Why?
|
Humans | 209 | 2020 | 124700 | 0.470 |
Why?
|
Male | 128 | 2024 | 61314 | 0.460 |
Why?
|
Infant Food | 10 | 2010 | 81 | 0.440 |
Why?
|
Indians, North American | 5 | 1997 | 58 | 0.430 |
Why?
|
Deglutition | 2 | 2012 | 49 | 0.430 |
Why?
|
Energy Intake | 12 | 2004 | 493 | 0.430 |
Why?
|
Dietary Supplements | 5 | 2013 | 476 | 0.430 |
Why?
|
Irritable Bowel Syndrome | 2 | 2017 | 206 | 0.420 |
Why?
|
Infant | 74 | 2020 | 12381 | 0.410 |
Why?
|
Basal Metabolism | 9 | 2003 | 95 | 0.410 |
Why?
|
Lactose | 3 | 2005 | 54 | 0.410 |
Why?
|
Adolescent | 66 | 2019 | 19216 | 0.400 |
Why?
|
Postmenopause | 2 | 2010 | 126 | 0.400 |
Why?
|
Pacifiers | 1 | 2012 | 5 | 0.400 |
Why?
|
Rett Syndrome | 4 | 2009 | 291 | 0.390 |
Why?
|
Intestinal Mucosa | 3 | 2005 | 777 | 0.380 |
Why?
|
Receptors, Adrenergic, beta | 4 | 2000 | 62 | 0.370 |
Why?
|
Body Mass Index | 12 | 2016 | 1562 | 0.370 |
Why?
|
Growth | 9 | 2000 | 106 | 0.360 |
Why?
|
Lactase | 3 | 2010 | 40 | 0.360 |
Why?
|
Child | 69 | 2019 | 24170 | 0.360 |
Why?
|
Adipocytes | 7 | 2005 | 141 | 0.350 |
Why?
|
Gastrointestinal Contents | 1 | 2010 | 13 | 0.350 |
Why?
|
Motor Skills | 1 | 2011 | 83 | 0.350 |
Why?
|
Eating | 4 | 2010 | 368 | 0.350 |
Why?
|
Gestational Age | 14 | 2018 | 1161 | 0.340 |
Why?
|
Bone Density | 3 | 2009 | 318 | 0.340 |
Why?
|
Adult | 64 | 2020 | 29555 | 0.330 |
Why?
|
Prospective Studies | 26 | 2019 | 6132 | 0.330 |
Why?
|
Child Development | 6 | 2012 | 267 | 0.320 |
Why?
|
Cholesterol, Dietary | 2 | 2008 | 46 | 0.320 |
Why?
|
Infant Formula | 2 | 2012 | 96 | 0.320 |
Why?
|
Child, Preschool | 55 | 2017 | 13882 | 0.320 |
Why?
|
Enterocolitis, Necrotizing | 6 | 2014 | 243 | 0.310 |
Why?
|
Betaine | 1 | 2009 | 22 | 0.310 |
Why?
|
Folic Acid | 2 | 2009 | 294 | 0.310 |
Why?
|
Thinness | 2 | 2014 | 69 | 0.310 |
Why?
|
Probiotics | 1 | 2012 | 215 | 0.310 |
Why?
|
Pregnancy | 26 | 2018 | 7171 | 0.310 |
Why?
|
Birth Weight | 9 | 2007 | 345 | 0.310 |
Why?
|
Metabolic Syndrome | 4 | 2005 | 341 | 0.300 |
Why?
|
Cholesterol 7-alpha-Hydroxylase | 1 | 2008 | 34 | 0.290 |
Why?
|
Receptors, Purinergic P1 | 2 | 1997 | 10 | 0.290 |
Why?
|
Cerebrum | 1 | 2008 | 33 | 0.290 |
Why?
|
Infant, Premature, Diseases | 3 | 2014 | 243 | 0.280 |
Why?
|
Umbilical Arteries | 3 | 2004 | 98 | 0.270 |
Why?
|
Cholesterol | 2 | 2008 | 539 | 0.260 |
Why?
|
Nutritional Requirements | 7 | 2016 | 181 | 0.250 |
Why?
|
Texas | 18 | 2017 | 3561 | 0.250 |
Why?
|
Pregnancy in Adolescence | 1 | 2006 | 49 | 0.250 |
Why?
|
Milk Banks | 1 | 2005 | 4 | 0.250 |
Why?
|
Infant, Very Low Birth Weight | 5 | 2014 | 172 | 0.250 |
Why?
|
Minerals | 3 | 2000 | 57 | 0.250 |
Why?
|
Depression, Postpartum | 1 | 2006 | 50 | 0.250 |
Why?
|
Models, Biological | 8 | 2002 | 1460 | 0.240 |
Why?
|
Behavior, Animal | 1 | 2008 | 490 | 0.240 |
Why?
|
Bottle Feeding | 5 | 2011 | 36 | 0.240 |
Why?
|
Lenses | 1 | 2004 | 5 | 0.240 |
Why?
|
Mass Screening | 5 | 2016 | 772 | 0.230 |
Why?
|
Catheterization, Peripheral | 2 | 2004 | 125 | 0.230 |
Why?
|
Optic Disk | 1 | 2024 | 44 | 0.220 |
Why?
|
Double-Blind Method | 9 | 2019 | 1637 | 0.220 |
Why?
|
Body Water | 9 | 2003 | 90 | 0.220 |
Why?
|
Diet | 8 | 2016 | 1141 | 0.220 |
Why?
|
Graft Rejection | 5 | 2012 | 590 | 0.210 |
Why?
|
Animal Nutritional Physiological Phenomena | 2 | 2008 | 63 | 0.210 |
Why?
|
School Health Services | 4 | 2016 | 95 | 0.210 |
Why?
|
Retinal Ganglion Cells | 1 | 2024 | 99 | 0.210 |
Why?
|
Heart Transplantation | 5 | 2008 | 855 | 0.210 |
Why?
|
Lung Diseases, Interstitial | 3 | 2012 | 149 | 0.210 |
Why?
|
Nitrogen | 6 | 2001 | 146 | 0.210 |
Why?
|
Weaning | 3 | 1997 | 44 | 0.210 |
Why?
|
Macaca mulatta | 1 | 2024 | 491 | 0.210 |
Why?
|
Anthropometry | 9 | 2003 | 197 | 0.200 |
Why?
|
Menopause | 2 | 2013 | 77 | 0.200 |
Why?
|
Motor Activity | 3 | 2011 | 522 | 0.200 |
Why?
|
Potassium | 6 | 2000 | 282 | 0.190 |
Why?
|
Diabetes Mellitus, Type 1 | 4 | 2014 | 817 | 0.190 |
Why?
|
Time Factors | 20 | 2014 | 6323 | 0.190 |
Why?
|
Bronchiolitis Obliterans | 2 | 2012 | 40 | 0.190 |
Why?
|
Weight Gain | 3 | 2003 | 403 | 0.190 |
Why?
|
Risk Factors | 26 | 2016 | 10249 | 0.180 |
Why?
|
Age Factors | 18 | 2014 | 2807 | 0.180 |
Why?
|
Mucin-1 | 3 | 2010 | 35 | 0.180 |
Why?
|
Tuberculosis | 2 | 2016 | 443 | 0.180 |
Why?
|
Severity of Illness Index | 12 | 2014 | 2900 | 0.180 |
Why?
|
Intestine, Small | 2 | 2005 | 309 | 0.180 |
Why?
|
Reproduction | 1 | 2003 | 236 | 0.180 |
Why?
|
Natriuretic Peptide, Brain | 3 | 2008 | 312 | 0.180 |
Why?
|
Physical Exertion | 2 | 1999 | 80 | 0.180 |
Why?
|
Longitudinal Studies | 15 | 2010 | 1327 | 0.170 |
Why?
|
Death, Sudden, Cardiac | 3 | 2009 | 257 | 0.170 |
Why?
|
Calcification, Physiologic | 1 | 2000 | 22 | 0.170 |
Why?
|
Plant Extracts | 2 | 2012 | 121 | 0.170 |
Why?
|
Cardiac Surgical Procedures | 6 | 2008 | 1117 | 0.170 |
Why?
|
Sleep | 3 | 2013 | 344 | 0.170 |
Why?
|
Colitis, Ulcerative | 2 | 2014 | 205 | 0.170 |
Why?
|
Cardiomyopathy, Dilated | 4 | 2009 | 213 | 0.170 |
Why?
|
beta-Galactosidase | 2 | 1998 | 147 | 0.160 |
Why?
|
Mother-Child Relations | 1 | 2020 | 77 | 0.160 |
Why?
|
Early Diagnosis | 1 | 2020 | 181 | 0.160 |
Why?
|
Myopia, Degenerative | 1 | 2019 | 9 | 0.160 |
Why?
|
Contact Lenses, Hydrophilic | 1 | 2019 | 21 | 0.160 |
Why?
|
Lung Transplantation | 3 | 2012 | 320 | 0.160 |
Why?
|
Oxygen Consumption | 4 | 2003 | 306 | 0.160 |
Why?
|
Tomography, Optical Coherence | 1 | 2024 | 522 | 0.160 |
Why?
|
Exercise | 7 | 2016 | 817 | 0.160 |
Why?
|
Puberty | 2 | 1999 | 95 | 0.160 |
Why?
|
Animals, Suckling | 2 | 1999 | 50 | 0.160 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2011 | 156 | 0.150 |
Why?
|
Niacin | 2 | 2011 | 58 | 0.150 |
Why?
|
Pertussis Toxin | 1 | 2018 | 28 | 0.150 |
Why?
|
Fenofibrate | 2 | 2011 | 59 | 0.150 |
Why?
|
Aging | 5 | 2007 | 1183 | 0.150 |
Why?
|
Insulin | 6 | 2013 | 1204 | 0.150 |
Why?
|
Biomarkers | 8 | 2014 | 3083 | 0.150 |
Why?
|
Predictive Value of Tests | 13 | 2014 | 2161 | 0.150 |
Why?
|
Analysis of Variance | 11 | 2019 | 1021 | 0.150 |
Why?
|
Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2018 | 35 | 0.150 |
Why?
|
Proteins | 3 | 2004 | 1035 | 0.150 |
Why?
|
Whooping Cough | 1 | 2018 | 58 | 0.150 |
Why?
|
Bone and Bones | 1 | 2000 | 266 | 0.150 |
Why?
|
Antibodies, Bacterial | 3 | 2018 | 388 | 0.150 |
Why?
|
Cross-Sectional Studies | 11 | 2014 | 3415 | 0.140 |
Why?
|
Regression Analysis | 12 | 2007 | 778 | 0.140 |
Why?
|
Poverty | 4 | 2016 | 421 | 0.140 |
Why?
|
Students | 2 | 2016 | 248 | 0.140 |
Why?
|
Reference Values | 9 | 2014 | 715 | 0.140 |
Why?
|
Treatment Outcome | 22 | 2014 | 12363 | 0.140 |
Why?
|
Dietary Fats | 5 | 2006 | 297 | 0.140 |
Why?
|
Cardiac Output | 2 | 1988 | 171 | 0.140 |
Why?
|
Infant Nutritional Physiological Phenomena | 7 | 2007 | 193 | 0.140 |
Why?
|
Retrospective Studies | 28 | 2017 | 16262 | 0.140 |
Why?
|
Calorimetry, Indirect | 5 | 2003 | 56 | 0.140 |
Why?
|
Natriuretic Agents | 2 | 2007 | 33 | 0.140 |
Why?
|
Placebos | 5 | 2013 | 241 | 0.130 |
Why?
|
Surveys and Questionnaires | 6 | 2020 | 3714 | 0.130 |
Why?
|
Anti-Inflammatory Agents | 2 | 2014 | 292 | 0.130 |
Why?
|
Gonadal Dysgenesis, 46,XY | 1 | 2016 | 16 | 0.130 |
Why?
|
Respiratory Distress Syndrome, Newborn | 2 | 2014 | 78 | 0.130 |
Why?
|
Sex Reassignment Procedures | 1 | 2016 | 15 | 0.130 |
Why?
|
Breath Tests | 6 | 2009 | 178 | 0.130 |
Why?
|
Follow-Up Studies | 16 | 2014 | 5154 | 0.130 |
Why?
|
Splanchnic Circulation | 2 | 2014 | 53 | 0.130 |
Why?
|
Bronchopulmonary Dysplasia | 2 | 2010 | 191 | 0.130 |
Why?
|
Glucocorticoids | 1 | 1998 | 381 | 0.130 |
Why?
|
Animals, Newborn | 5 | 2008 | 1017 | 0.130 |
Why?
|
Hospitals, Pediatric | 4 | 2014 | 749 | 0.120 |
Why?
|
Methyl-CpG-Binding Protein 2 | 2 | 2009 | 309 | 0.120 |
Why?
|
Community Health Services | 1 | 2016 | 89 | 0.120 |
Why?
|
Staphylococcal Infections | 3 | 2012 | 558 | 0.120 |
Why?
|
Hyperglycemia | 2 | 2008 | 225 | 0.120 |
Why?
|
Blood Glucose | 5 | 2008 | 1136 | 0.120 |
Why?
|
Calorimetry | 5 | 2006 | 62 | 0.120 |
Why?
|
Oxygen | 4 | 2014 | 555 | 0.120 |
Why?
|
Adolescent Behavior | 1 | 2016 | 167 | 0.120 |
Why?
|
Health Education | 1 | 2016 | 219 | 0.120 |
Why?
|
Evidence-Based Practice | 1 | 2016 | 112 | 0.120 |
Why?
|
Blood Pressure | 5 | 2012 | 1369 | 0.120 |
Why?
|
Residence Characteristics | 2 | 2014 | 278 | 0.120 |
Why?
|
Methotrexate | 1 | 2017 | 337 | 0.110 |
Why?
|
Point-of-Care Systems | 1 | 2017 | 173 | 0.110 |
Why?
|
Lipid Metabolism | 4 | 2006 | 357 | 0.110 |
Why?
|
Absorptiometry, Photon | 5 | 2002 | 177 | 0.110 |
Why?
|
Lactose Intolerance | 3 | 2005 | 9 | 0.110 |
Why?
|
Gastroenterology | 1 | 2017 | 196 | 0.110 |
Why?
|
Catecholamines | 2 | 1999 | 59 | 0.110 |
Why?
|
Swine Diseases | 3 | 1999 | 38 | 0.110 |
Why?
|
Referral and Consultation | 2 | 2017 | 538 | 0.110 |
Why?
|
Practice Patterns, Physicians' | 2 | 2017 | 726 | 0.110 |
Why?
|
Larynx, Artificial | 1 | 2013 | 4 | 0.110 |
Why?
|
Hepatitis B Antibodies | 1 | 2013 | 24 | 0.110 |
Why?
|
Respiratory Aspiration | 1 | 2013 | 8 | 0.110 |
Why?
|
Forced Expiratory Volume | 2 | 2012 | 171 | 0.110 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2011 | 109 | 0.110 |
Why?
|
Mitochondrial Diseases | 2 | 2006 | 133 | 0.110 |
Why?
|
Algorithms | 3 | 2017 | 1625 | 0.110 |
Why?
|
Prognosis | 8 | 2013 | 4620 | 0.110 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2013 | 51 | 0.110 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2014 | 144 | 0.110 |
Why?
|
Gastrointestinal Agents | 1 | 2014 | 60 | 0.110 |
Why?
|
Respiratory Function Tests | 2 | 2011 | 198 | 0.110 |
Why?
|
Urban Population | 2 | 2014 | 225 | 0.110 |
Why?
|
Animals | 27 | 2024 | 34234 | 0.110 |
Why?
|
Guinea Pigs | 2 | 1985 | 166 | 0.110 |
Why?
|
Blood Urea Nitrogen | 2 | 2010 | 74 | 0.110 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2014 | 53 | 0.110 |
Why?
|
Middle Aged | 22 | 2013 | 26884 | 0.100 |
Why?
|
Glutamate Decarboxylase | 1 | 2013 | 37 | 0.100 |
Why?
|
Linear Models | 2 | 2012 | 682 | 0.100 |
Why?
|
Indomethacin | 3 | 2003 | 84 | 0.100 |
Why?
|
Health Promotion | 1 | 2016 | 388 | 0.100 |
Why?
|
Adiposity | 1 | 2014 | 190 | 0.100 |
Why?
|
Adiponectin | 2 | 2011 | 114 | 0.100 |
Why?
|
Hematologic Diseases | 1 | 2013 | 79 | 0.100 |
Why?
|
Carbon Isotopes | 3 | 2009 | 277 | 0.100 |
Why?
|
Mexico | 5 | 1997 | 181 | 0.100 |
Why?
|
Hepatitis B virus | 1 | 2013 | 130 | 0.100 |
Why?
|
Larynx | 1 | 2013 | 72 | 0.100 |
Why?
|
C-Peptide | 1 | 2013 | 113 | 0.100 |
Why?
|
Infant, Low Birth Weight | 5 | 2005 | 166 | 0.100 |
Why?
|
Hepatitis B | 1 | 2013 | 159 | 0.100 |
Why?
|
Heart Septal Defects, Atrial | 2 | 2005 | 118 | 0.100 |
Why?
|
Healthcare Disparities | 1 | 2017 | 432 | 0.100 |
Why?
|
Islets of Langerhans | 1 | 2013 | 174 | 0.100 |
Why?
|
Nutritional Status | 2 | 2011 | 314 | 0.100 |
Why?
|
Fractures, Spontaneous | 1 | 2012 | 18 | 0.100 |
Why?
|
Critical Illness | 4 | 2001 | 599 | 0.100 |
Why?
|
Heart Function Tests | 1 | 2011 | 57 | 0.100 |
Why?
|
Sepsis | 6 | 2005 | 479 | 0.100 |
Why?
|
Intestinal Absorption | 3 | 2005 | 190 | 0.090 |
Why?
|
Deglutition Disorders | 1 | 2013 | 131 | 0.090 |
Why?
|
Lung | 2 | 2010 | 1496 | 0.090 |
Why?
|
Echocardiography | 7 | 2011 | 1053 | 0.090 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2011 | 29 | 0.090 |
Why?
|
Water Microbiology | 1 | 1991 | 25 | 0.090 |
Why?
|
Primary Health Care | 2 | 2017 | 769 | 0.090 |
Why?
|
Water Supply | 1 | 1991 | 26 | 0.090 |
Why?
|
Socioeconomic Factors | 3 | 2014 | 867 | 0.090 |
Why?
|
Meningitis, Haemophilus | 2 | 1988 | 34 | 0.090 |
Why?
|
Lactulose | 3 | 1998 | 39 | 0.090 |
Why?
|
Tracheostomy | 1 | 2013 | 192 | 0.090 |
Why?
|
Weight Reduction Programs | 1 | 2012 | 56 | 0.090 |
Why?
|
Skinfold Thickness | 5 | 2000 | 31 | 0.090 |
Why?
|
Phytoestrogens | 1 | 2010 | 16 | 0.090 |
Why?
|
Postoperative Complications | 6 | 2014 | 3067 | 0.090 |
Why?
|
Cardiac Catheterization | 4 | 2011 | 634 | 0.090 |
Why?
|
Risk | 4 | 2012 | 752 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 1695 | 0.090 |
Why?
|
Task Performance and Analysis | 1 | 2011 | 92 | 0.090 |
Why?
|
Cardiac Output, Low | 2 | 2007 | 67 | 0.090 |
Why?
|
Lung Diseases | 2 | 2010 | 383 | 0.090 |
Why?
|
Leukocyte L1 Antigen Complex | 1 | 2010 | 15 | 0.090 |
Why?
|
Intestines | 1 | 2014 | 576 | 0.090 |
Why?
|
Heart Failure | 4 | 2009 | 2297 | 0.090 |
Why?
|
Case-Control Studies | 5 | 2014 | 3292 | 0.090 |
Why?
|
Reflex, Pupillary | 1 | 2010 | 15 | 0.090 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 846 | 0.090 |
Why?
|
Mouth | 1 | 2011 | 62 | 0.090 |
Why?
|
Hypertension | 6 | 2011 | 1329 | 0.090 |
Why?
|
Intubation, Gastrointestinal | 1 | 2010 | 51 | 0.090 |
Why?
|
HIV Seropositivity | 1 | 2011 | 121 | 0.090 |
Why?
|
Emphysema | 1 | 2011 | 67 | 0.090 |
Why?
|
Risk Reduction Behavior | 1 | 2011 | 143 | 0.080 |
Why?
|
Gastric Emptying | 1 | 2010 | 78 | 0.080 |
Why?
|
Interferon Regulatory Factors | 1 | 2010 | 37 | 0.080 |
Why?
|
Autoantibodies | 1 | 2013 | 434 | 0.080 |
Why?
|
Survival Analysis | 7 | 2014 | 1504 | 0.080 |
Why?
|
Attitude to Health | 1 | 2011 | 256 | 0.080 |
Why?
|
Fatty Liver | 1 | 2011 | 187 | 0.080 |
Why?
|
Heart Rate | 5 | 2007 | 589 | 0.080 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 782 | 0.080 |
Why?
|
Anti-Retroviral Agents | 1 | 2011 | 139 | 0.080 |
Why?
|
Prevalence | 4 | 2013 | 2446 | 0.080 |
Why?
|
Positive-Pressure Respiration | 2 | 2001 | 83 | 0.080 |
Why?
|
Respiration, Artificial | 4 | 2001 | 461 | 0.080 |
Why?
|
Ventricular Function, Left | 2 | 2011 | 508 | 0.080 |
Why?
|
Hypoxia | 2 | 1989 | 248 | 0.080 |
Why?
|
beta-Fructofuranosidase | 1 | 2009 | 2 | 0.080 |
Why?
|
Statistics as Topic | 3 | 2004 | 256 | 0.080 |
Why?
|
Behavior Therapy | 1 | 2012 | 253 | 0.080 |
Why?
|
Facial Nerve Diseases | 1 | 2009 | 6 | 0.080 |
Why?
|
Leptin | 5 | 2005 | 214 | 0.080 |
Why?
|
Pulmonary Surfactant-Associated Protein C | 1 | 2009 | 5 | 0.080 |
Why?
|
Sucrase-Isomaltase Complex | 1 | 2009 | 19 | 0.080 |
Why?
|
Retinoblastoma | 1 | 2010 | 110 | 0.080 |
Why?
|
Sensitivity and Specificity | 7 | 2012 | 2043 | 0.080 |
Why?
|
Sucrose | 1 | 2009 | 39 | 0.080 |
Why?
|
Facial Paralysis | 1 | 2009 | 35 | 0.080 |
Why?
|
Lipid Metabolism, Inborn Errors | 1 | 2009 | 20 | 0.080 |
Why?
|
Patient Compliance | 3 | 1997 | 469 | 0.080 |
Why?
|
Body Height | 10 | 2000 | 215 | 0.080 |
Why?
|
Neuroendocrine Cells | 1 | 2009 | 9 | 0.080 |
Why?
|
Retinal Neoplasms | 1 | 2010 | 100 | 0.080 |
Why?
|
Osteomyelitis | 1 | 2012 | 205 | 0.080 |
Why?
|
Defibrillators | 1 | 2009 | 20 | 0.080 |
Why?
|
Follicle Stimulating Hormone | 1 | 2009 | 186 | 0.080 |
Why?
|
Pediatric Obesity | 1 | 2014 | 383 | 0.080 |
Why?
|
Feces | 2 | 2010 | 726 | 0.080 |
Why?
|
Hypolipidemic Agents | 2 | 2011 | 181 | 0.080 |
Why?
|
Carbohydrate Metabolism, Inborn Errors | 1 | 2009 | 36 | 0.080 |
Why?
|
Animal Feed | 2 | 2008 | 79 | 0.080 |
Why?
|
Nitric Oxide | 1 | 2012 | 492 | 0.080 |
Why?
|
Social Class | 3 | 2017 | 190 | 0.080 |
Why?
|
Recurrence | 3 | 2010 | 1415 | 0.080 |
Why?
|
Neovascularization, Pathologic | 1 | 2010 | 240 | 0.080 |
Why?
|
Virus Activation | 2 | 2013 | 87 | 0.080 |
Why?
|
Cytokines | 4 | 2014 | 1286 | 0.080 |
Why?
|
Chemotaxis, Leukocyte | 2 | 2006 | 63 | 0.080 |
Why?
|
Electric Countershock | 1 | 2009 | 67 | 0.080 |
Why?
|
Moxalactam | 1 | 1988 | 21 | 0.080 |
Why?
|
Pregnancy Trimester, Third | 2 | 2018 | 119 | 0.080 |
Why?
|
Chloramphenicol | 1 | 1988 | 28 | 0.080 |
Why?
|
Models, Statistical | 3 | 2000 | 472 | 0.070 |
Why?
|
Ampicillin | 1 | 1988 | 56 | 0.070 |
Why?
|
Milk Substitutes | 1 | 2008 | 7 | 0.070 |
Why?
|
Dyslipidemias | 1 | 2011 | 235 | 0.070 |
Why?
|
Patient Discharge | 2 | 2010 | 489 | 0.070 |
Why?
|
Pulmonary Veins | 1 | 2010 | 161 | 0.070 |
Why?
|
DNA, Mitochondrial | 2 | 2006 | 211 | 0.070 |
Why?
|
Dogs | 3 | 2006 | 774 | 0.070 |
Why?
|
Polyomavirus Infections | 1 | 2009 | 90 | 0.070 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 1032 | 0.070 |
Why?
|
Vitamin D | 1 | 2009 | 161 | 0.070 |
Why?
|
Simian virus 40 | 1 | 2009 | 199 | 0.070 |
Why?
|
Calcium | 4 | 2009 | 1101 | 0.070 |
Why?
|
Seizures | 2 | 2010 | 870 | 0.070 |
Why?
|
Life Style | 2 | 2011 | 414 | 0.070 |
Why?
|
Crohn Disease | 1 | 2011 | 282 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 1 | 2010 | 372 | 0.070 |
Why?
|
Neutrophils | 3 | 2006 | 382 | 0.070 |
Why?
|
Immunoassay | 3 | 2008 | 130 | 0.070 |
Why?
|
Air Ambulances | 1 | 2007 | 24 | 0.070 |
Why?
|
F2-Isoprostanes | 1 | 2007 | 20 | 0.070 |
Why?
|
Logistic Models | 6 | 2017 | 1807 | 0.070 |
Why?
|
Cachexia | 1 | 2007 | 47 | 0.070 |
Why?
|
Heart Block | 1 | 2007 | 40 | 0.070 |
Why?
|
Transportation of Patients | 1 | 2007 | 54 | 0.070 |
Why?
|
Heart Defects, Congenital | 3 | 2008 | 1816 | 0.070 |
Why?
|
Deuterium | 5 | 2003 | 109 | 0.070 |
Why?
|
Echocardiography, Doppler | 1 | 1988 | 171 | 0.070 |
Why?
|
Wounds and Injuries | 1 | 2010 | 366 | 0.070 |
Why?
|
Organ Size | 1 | 2008 | 436 | 0.070 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2009 | 238 | 0.070 |
Why?
|
Myelin Sheath | 1 | 2007 | 122 | 0.070 |
Why?
|
Brain | 3 | 2009 | 2997 | 0.070 |
Why?
|
Cardiomyopathies | 3 | 2007 | 495 | 0.070 |
Why?
|
Clinical Trials as Topic | 5 | 1993 | 1090 | 0.070 |
Why?
|
Premature Birth | 1 | 2011 | 385 | 0.070 |
Why?
|
Gene Products, vpr | 1 | 2006 | 20 | 0.070 |
Why?
|
Cardiotonic Agents | 1 | 1988 | 139 | 0.070 |
Why?
|
Odds Ratio | 4 | 2014 | 1253 | 0.070 |
Why?
|
Diet, Fat-Restricted | 1 | 2006 | 40 | 0.070 |
Why?
|
Ventricular Function | 1 | 2007 | 91 | 0.070 |
Why?
|
HIV-Associated Lipodystrophy Syndrome | 1 | 2006 | 28 | 0.070 |
Why?
|
Promoter Regions, Genetic | 1 | 2010 | 1330 | 0.060 |
Why?
|
Ultrasonography | 6 | 2013 | 938 | 0.060 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2007 | 118 | 0.060 |
Why?
|
Age of Onset | 4 | 2014 | 591 | 0.060 |
Why?
|
Hydrogen | 2 | 1985 | 41 | 0.060 |
Why?
|
Outpatient Clinics, Hospital | 2 | 1985 | 72 | 0.060 |
Why?
|
Pulmonary Surfactants | 2 | 1998 | 43 | 0.060 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2006 | 141 | 0.060 |
Why?
|
Interleukin-6 | 3 | 2005 | 418 | 0.060 |
Why?
|
Catheterization | 2 | 2005 | 234 | 0.060 |
Why?
|
Cryopreservation | 1 | 2006 | 73 | 0.060 |
Why?
|
Stroke Volume | 5 | 2011 | 489 | 0.060 |
Why?
|
Chemokines, CC | 1 | 2005 | 28 | 0.060 |
Why?
|
Rural Population | 4 | 1996 | 256 | 0.060 |
Why?
|
Developmental Disabilities | 2 | 2007 | 711 | 0.060 |
Why?
|
Helicobacter pylori | 2 | 1994 | 1320 | 0.060 |
Why?
|
Intraoperative Complications | 1 | 2007 | 170 | 0.060 |
Why?
|
Multivariate Analysis | 7 | 2011 | 1437 | 0.060 |
Why?
|
Tetrahydrofolates | 1 | 2005 | 17 | 0.060 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2010 | 301 | 0.060 |
Why?
|
Helicobacter Infections | 2 | 1994 | 1263 | 0.060 |
Why?
|
Breeding | 2 | 1997 | 20 | 0.060 |
Why?
|
Insulin Infusion Systems | 1 | 2005 | 65 | 0.060 |
Why?
|
Child Health Services | 2 | 2016 | 84 | 0.060 |
Why?
|
Simethicone | 1 | 1985 | 3 | 0.060 |
Why?
|
Silicones | 1 | 1985 | 36 | 0.060 |
Why?
|
Quality of Life | 2 | 2013 | 1936 | 0.060 |
Why?
|
Infant, Newborn, Diseases | 2 | 2006 | 170 | 0.060 |
Why?
|
Pulmonary Surfactant-Associated Protein A | 1 | 2005 | 5 | 0.060 |
Why?
|
Pulmonary Surfactant-Associated Protein D | 1 | 2005 | 9 | 0.060 |
Why?
|
Food, Fortified | 1 | 1985 | 96 | 0.060 |
Why?
|
Cerebrospinal Fluid | 1 | 2005 | 93 | 0.060 |
Why?
|
Effect Modifier, Epidemiologic | 1 | 2004 | 10 | 0.060 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2005 | 64 | 0.060 |
Why?
|
Platelet Transfusion | 1 | 2005 | 53 | 0.060 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2006 | 142 | 0.060 |
Why?
|
Environment | 1 | 2005 | 145 | 0.060 |
Why?
|
Digestion | 1 | 2005 | 41 | 0.060 |
Why?
|
Renal Dialysis | 1 | 2011 | 854 | 0.060 |
Why?
|
Incidence | 6 | 2012 | 3115 | 0.060 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2006 | 266 | 0.060 |
Why?
|
Sex Distribution | 3 | 2000 | 303 | 0.060 |
Why?
|
Electron Transport Chain Complex Proteins | 1 | 2004 | 23 | 0.060 |
Why?
|
Ventricular Remodeling | 1 | 2005 | 184 | 0.060 |
Why?
|
Hyperlipidemias | 1 | 2006 | 178 | 0.060 |
Why?
|
Antigens | 1 | 2005 | 156 | 0.060 |
Why?
|
Nutrition Surveys | 4 | 2011 | 293 | 0.060 |
Why?
|
Developing Countries | 3 | 2014 | 265 | 0.060 |
Why?
|
Cohort Studies | 7 | 2009 | 4799 | 0.060 |
Why?
|
Empyema, Pleural | 1 | 2004 | 25 | 0.060 |
Why?
|
Heart Arrest | 1 | 2009 | 351 | 0.060 |
Why?
|
Adenoidectomy | 1 | 2005 | 76 | 0.060 |
Why?
|
Exudates and Transudates | 1 | 2004 | 21 | 0.060 |
Why?
|
Axial Length, Eye | 1 | 2024 | 49 | 0.060 |
Why?
|
Arginine Vasopressin | 1 | 2004 | 28 | 0.060 |
Why?
|
Nerve Fibers | 1 | 2024 | 73 | 0.060 |
Why?
|
Otitis Media with Effusion | 1 | 2004 | 18 | 0.060 |
Why?
|
Pre-Excitation Syndromes | 1 | 2003 | 3 | 0.060 |
Why?
|
Infusions, Intravenous | 3 | 2017 | 554 | 0.060 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2004 | 55 | 0.060 |
Why?
|
Neuromuscular Diseases | 1 | 2004 | 56 | 0.060 |
Why?
|
Macula Lutea | 1 | 2024 | 45 | 0.060 |
Why?
|
Body Constitution | 3 | 1995 | 36 | 0.050 |
Why?
|
Combined Modality Therapy | 3 | 2006 | 1236 | 0.050 |
Why?
|
Seasons | 2 | 2003 | 312 | 0.050 |
Why?
|
Dietary Proteins | 3 | 2001 | 251 | 0.050 |
Why?
|
Linoleic Acids, Conjugated | 1 | 2003 | 1 | 0.050 |
Why?
|
Perfusion | 1 | 2005 | 207 | 0.050 |
Why?
|
Tissue Distribution | 2 | 2000 | 391 | 0.050 |
Why?
|
DNA, Viral | 3 | 2013 | 480 | 0.050 |
Why?
|
Digoxin | 1 | 2003 | 43 | 0.050 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2004 | 369 | 0.050 |
Why?
|
DNA Methylation | 1 | 2010 | 1008 | 0.050 |
Why?
|
Tonsillectomy | 1 | 2005 | 99 | 0.050 |
Why?
|
JC Virus | 1 | 2003 | 30 | 0.050 |
Why?
|
Propranolol | 1 | 2003 | 127 | 0.050 |
Why?
|
Terbutaline | 2 | 1993 | 6 | 0.050 |
Why?
|
Alleles | 1 | 2008 | 1615 | 0.050 |
Why?
|
Virus Shedding | 1 | 2003 | 80 | 0.050 |
Why?
|
Transposition of Great Vessels | 1 | 2004 | 130 | 0.050 |
Why?
|
Intestinal Perforation | 1 | 2003 | 56 | 0.050 |
Why?
|
Thrombocytopenia | 1 | 2005 | 224 | 0.050 |
Why?
|
Sex Factors | 5 | 2013 | 1287 | 0.050 |
Why?
|
Myocardium | 1 | 2008 | 1019 | 0.050 |
Why?
|
BK Virus | 1 | 2003 | 60 | 0.050 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2004 | 282 | 0.050 |
Why?
|
Cell Adhesion Molecules | 1 | 2004 | 230 | 0.050 |
Why?
|
Physical Fitness | 1 | 2003 | 90 | 0.050 |
Why?
|
Aortic Valve Insufficiency | 1 | 2004 | 143 | 0.050 |
Why?
|
Inflammation | 3 | 2006 | 1440 | 0.050 |
Why?
|
Colon | 1 | 1985 | 349 | 0.050 |
Why?
|
Program Evaluation | 2 | 2016 | 442 | 0.050 |
Why?
|
Glycoproteins | 1 | 2005 | 370 | 0.050 |
Why?
|
DiGeorge Syndrome | 1 | 2003 | 79 | 0.050 |
Why?
|
Tachycardia, Supraventricular | 1 | 2003 | 109 | 0.050 |
Why?
|
Ductus Arteriosus, Patent | 2 | 2003 | 143 | 0.050 |
Why?
|
Sialoglycoproteins | 1 | 2002 | 48 | 0.050 |
Why?
|
Cardiovascular Agents | 1 | 2003 | 90 | 0.050 |
Why?
|
Meningococcal Infections | 1 | 2002 | 19 | 0.050 |
Why?
|
Rest | 2 | 1999 | 58 | 0.050 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2003 | 223 | 0.050 |
Why?
|
Hypocotyl | 2 | 2012 | 6 | 0.050 |
Why?
|
Computers | 2 | 1983 | 68 | 0.050 |
Why?
|
Pneumococcal Infections | 1 | 2004 | 274 | 0.050 |
Why?
|
Cell Differentiation | 3 | 2005 | 1896 | 0.050 |
Why?
|
Cytomegalovirus | 1 | 2003 | 269 | 0.050 |
Why?
|
Reproducibility of Results | 5 | 2010 | 2885 | 0.050 |
Why?
|
Treatment Refusal | 1 | 2002 | 77 | 0.050 |
Why?
|
Drug Therapy | 1 | 1982 | 85 | 0.050 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2005 | 205 | 0.050 |
Why?
|
Postpericardiotomy Syndrome | 1 | 2001 | 4 | 0.050 |
Why?
|
Airway Resistance | 1 | 2001 | 36 | 0.050 |
Why?
|
Premedication | 1 | 2001 | 42 | 0.050 |
Why?
|
Neoplasms | 2 | 2013 | 2780 | 0.050 |
Why?
|
Paracentesis | 1 | 2001 | 16 | 0.050 |
Why?
|
Observer Variation | 3 | 2010 | 299 | 0.050 |
Why?
|
Peritoneum | 1 | 2001 | 37 | 0.050 |
Why?
|
Adolescent Health Services | 2 | 2000 | 36 | 0.050 |
Why?
|
Lipids | 2 | 1998 | 521 | 0.040 |
Why?
|
Pediatrics | 3 | 2017 | 1143 | 0.040 |
Why?
|
Aftercare | 1 | 2002 | 146 | 0.040 |
Why?
|
Ganciclovir | 1 | 2001 | 103 | 0.040 |
Why?
|
Methylprednisolone | 1 | 2001 | 91 | 0.040 |
Why?
|
Interleukin-10 | 1 | 2002 | 174 | 0.040 |
Why?
|
Models, Theoretical | 2 | 1980 | 359 | 0.040 |
Why?
|
Dietary Carbohydrates | 1 | 2001 | 119 | 0.040 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2001 | 70 | 0.040 |
Why?
|
Parenteral Nutrition | 2 | 2001 | 194 | 0.040 |
Why?
|
Simplexvirus | 1 | 2001 | 104 | 0.040 |
Why?
|
Rabbits | 2 | 2002 | 717 | 0.040 |
Why?
|
Young Adult | 2 | 2018 | 9022 | 0.040 |
Why?
|
Intensive Care Units, Pediatric | 2 | 2002 | 476 | 0.040 |
Why?
|
Aorta | 1 | 2004 | 547 | 0.040 |
Why?
|
Leukocytes | 1 | 2002 | 210 | 0.040 |
Why?
|
Cardiomyopathy, Restrictive | 1 | 2000 | 21 | 0.040 |
Why?
|
Hypoglycemia | 3 | 2008 | 189 | 0.040 |
Why?
|
Gastrointestinal Diseases | 2 | 2003 | 336 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2017 | 715 | 0.040 |
Why?
|
Electric Impedance | 1 | 2000 | 59 | 0.040 |
Why?
|
Dosage Compensation, Genetic | 1 | 2000 | 59 | 0.040 |
Why?
|
Sleep Deprivation | 1 | 2001 | 50 | 0.040 |
Why?
|
Food Deprivation | 1 | 2000 | 32 | 0.040 |
Why?
|
Heart Septal Defects, Ventricular | 2 | 2004 | 133 | 0.040 |
Why?
|
Triiodothyronine | 1 | 2000 | 62 | 0.040 |
Why?
|
Butyrates | 1 | 2000 | 35 | 0.040 |
Why?
|
Gene Expression | 2 | 2006 | 1561 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 2003 | 675 | 0.040 |
Why?
|
Interferon-gamma | 1 | 2002 | 498 | 0.040 |
Why?
|
Adrenergic beta-Agonists | 1 | 2000 | 94 | 0.040 |
Why?
|
Swine, Miniature | 2 | 1997 | 50 | 0.040 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 1999 | 9 | 0.040 |
Why?
|
Drainage | 1 | 2001 | 257 | 0.040 |
Why?
|
Plethysmography | 2 | 2010 | 35 | 0.040 |
Why?
|
Mutation | 3 | 2008 | 5845 | 0.040 |
Why?
|
Respiration | 3 | 2003 | 119 | 0.040 |
Why?
|
Space Flight | 1 | 2001 | 107 | 0.040 |
Why?
|
X Chromosome | 1 | 2000 | 338 | 0.040 |
Why?
|
Hyaline Membrane Disease | 1 | 1998 | 4 | 0.040 |
Why?
|
Carbon Dioxide | 4 | 2009 | 278 | 0.040 |
Why?
|
Cardiopulmonary Bypass | 1 | 2001 | 355 | 0.040 |
Why?
|
Soybean Proteins | 1 | 1998 | 17 | 0.040 |
Why?
|
Point Mutation | 1 | 2000 | 347 | 0.040 |
Why?
|
Erythroblastosis, Fetal | 1 | 1998 | 27 | 0.040 |
Why?
|
Fats | 3 | 1988 | 12 | 0.040 |
Why?
|
Mannitol | 1 | 1998 | 48 | 0.040 |
Why?
|
Sexual Maturation | 1 | 1998 | 47 | 0.040 |
Why?
|
Shock, Cardiogenic | 1 | 2000 | 192 | 0.040 |
Why?
|
Osmolar Concentration | 1 | 1998 | 176 | 0.040 |
Why?
|
Azathioprine | 1 | 1998 | 54 | 0.040 |
Why?
|
Dexamethasone | 1 | 2000 | 276 | 0.040 |
Why?
|
Blood Transfusion, Intrauterine | 1 | 1998 | 37 | 0.040 |
Why?
|
Exercise Test | 2 | 2011 | 254 | 0.040 |
Why?
|
Permeability | 1 | 1998 | 124 | 0.040 |
Why?
|
Hydrocortisone | 1 | 1999 | 218 | 0.040 |
Why?
|
Radioisotope Dilution Technique | 3 | 1989 | 43 | 0.040 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1999 | 256 | 0.040 |
Why?
|
Iodocyanopindolol | 1 | 1997 | 3 | 0.040 |
Why?
|
Drug Combinations | 2 | 2016 | 262 | 0.040 |
Why?
|
Pindolol | 1 | 1997 | 8 | 0.040 |
Why?
|
Hormones | 1 | 1999 | 186 | 0.040 |
Why?
|
Growth Disorders | 2 | 1992 | 209 | 0.040 |
Why?
|
Nervous System | 1 | 1998 | 127 | 0.040 |
Why?
|
Disease Models, Animal | 2 | 2024 | 4396 | 0.040 |
Why?
|
Chi-Square Distribution | 3 | 2011 | 588 | 0.040 |
Why?
|
Cyclosporine | 1 | 1998 | 147 | 0.040 |
Why?
|
Prednisone | 1 | 1998 | 271 | 0.040 |
Why?
|
Antiviral Agents | 2 | 2001 | 750 | 0.040 |
Why?
|
Medical Records | 2 | 2009 | 192 | 0.040 |
Why?
|
Medroxyprogesterone | 1 | 1997 | 8 | 0.040 |
Why?
|
Fasting | 1 | 1999 | 294 | 0.040 |
Why?
|
Peru | 3 | 1994 | 46 | 0.030 |
Why?
|
Amenorrhea | 1 | 1997 | 20 | 0.030 |
Why?
|
Muscle Proteins | 1 | 2000 | 417 | 0.030 |
Why?
|
Contraceptives, Oral | 1 | 1997 | 37 | 0.030 |
Why?
|
Weight Loss | 3 | 2005 | 483 | 0.030 |
Why?
|
Hospital Charges | 1 | 1997 | 60 | 0.030 |
Why?
|
Mucositis | 1 | 2017 | 19 | 0.030 |
Why?
|
Privacy | 1 | 1997 | 26 | 0.030 |
Why?
|
Hernia, Diaphragmatic | 1 | 1997 | 98 | 0.030 |
Why?
|
Mitral Valve | 2 | 2011 | 249 | 0.030 |
Why?
|
Family Practice | 1 | 1997 | 91 | 0.030 |
Why?
|
Hypothalamic Diseases | 1 | 1997 | 37 | 0.030 |
Why?
|
Models, Cardiovascular | 1 | 1998 | 185 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2003 | 947 | 0.030 |
Why?
|
Directly Observed Therapy | 1 | 2016 | 14 | 0.030 |
Why?
|
Genetic Therapy | 1 | 2001 | 687 | 0.030 |
Why?
|
Coronary Vessel Anomalies | 2 | 2004 | 280 | 0.030 |
Why?
|
Length of Stay | 2 | 2004 | 1305 | 0.030 |
Why?
|
Hypercholesterolemia | 1 | 1998 | 228 | 0.030 |
Why?
|
Aged | 8 | 2011 | 19830 | 0.030 |
Why?
|
Prosthesis Design | 1 | 2019 | 681 | 0.030 |
Why?
|
Postoperative Care | 1 | 1998 | 300 | 0.030 |
Why?
|
Area Under Curve | 1 | 2017 | 314 | 0.030 |
Why?
|
Isoniazid | 1 | 2016 | 52 | 0.030 |
Why?
|
Fluid Therapy | 1 | 2017 | 128 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2007 | 3561 | 0.030 |
Why?
|
Tuberculin Test | 1 | 2016 | 83 | 0.030 |
Why?
|
Random Allocation | 2 | 1988 | 441 | 0.030 |
Why?
|
Rifampin | 1 | 2016 | 124 | 0.030 |
Why?
|
Probability | 2 | 2010 | 321 | 0.030 |
Why?
|
Interviews as Topic | 1 | 1997 | 371 | 0.030 |
Why?
|
Salvage Therapy | 1 | 1997 | 192 | 0.030 |
Why?
|
Antigens, CD | 2 | 2008 | 431 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2009 | 1052 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2017 | 169 | 0.030 |
Why?
|
Triglycerides | 2 | 2011 | 577 | 0.030 |
Why?
|
Equipment Design | 2 | 2009 | 598 | 0.030 |
Why?
|
Cells, Cultured | 4 | 2003 | 3055 | 0.030 |
Why?
|
Aortic Coarctation | 1 | 1996 | 110 | 0.030 |
Why?
|
Creatinine | 2 | 2007 | 391 | 0.030 |
Why?
|
Biopsy | 2 | 2009 | 1234 | 0.030 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 2016 | 173 | 0.030 |
Why?
|
Angioplasty, Balloon | 1 | 1996 | 172 | 0.030 |
Why?
|
Fetus | 2 | 1992 | 584 | 0.030 |
Why?
|
Antitubercular Agents | 1 | 2016 | 185 | 0.030 |
Why?
|
Platelet Count | 2 | 2005 | 136 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 1999 | 1006 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 2 | 2009 | 458 | 0.030 |
Why?
|
Mesenteric Artery, Superior | 1 | 2014 | 35 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2003 | 1717 | 0.030 |
Why?
|
Isoproterenol | 2 | 2000 | 106 | 0.030 |
Why?
|
Intensive Care Units, Neonatal | 1 | 1997 | 313 | 0.030 |
Why?
|
United States | 5 | 2011 | 10866 | 0.030 |
Why?
|
Pulsatile Flow | 1 | 2014 | 128 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 1998 | 650 | 0.030 |
Why?
|
Decision Support Techniques | 1 | 1997 | 290 | 0.030 |
Why?
|
Transfusion Reaction | 1 | 2014 | 42 | 0.030 |
Why?
|
Heroin Dependence | 2 | 1985 | 56 | 0.030 |
Why?
|
Survival Rate | 2 | 2009 | 2055 | 0.030 |
Why?
|
Adipokines | 1 | 2014 | 60 | 0.030 |
Why?
|
Aortic Valve Stenosis | 1 | 1998 | 334 | 0.030 |
Why?
|
Infliximab | 1 | 2014 | 65 | 0.030 |
Why?
|
Cholestasis | 2 | 2005 | 153 | 0.030 |
Why?
|
Colectomy | 1 | 2014 | 74 | 0.030 |
Why?
|
Fatty Alcohols | 1 | 1993 | 5 | 0.030 |
Why?
|
Myocarditis | 1 | 1995 | 129 | 0.030 |
Why?
|
Phosphorylcholine | 1 | 1993 | 26 | 0.030 |
Why?
|
Haemophilus influenzae | 3 | 1988 | 129 | 0.030 |
Why?
|
Risk Assessment | 2 | 2013 | 3444 | 0.030 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2013 | 11 | 0.030 |
Why?
|
Accelerometry | 1 | 2013 | 60 | 0.030 |
Why?
|
Physician-Patient Relations | 1 | 1997 | 429 | 0.030 |
Why?
|
Infusion Pumps | 1 | 1993 | 33 | 0.030 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2014 | 90 | 0.030 |
Why?
|
Parents | 2 | 2017 | 1022 | 0.030 |
Why?
|
Pulmonary Alveoli | 2 | 2010 | 135 | 0.030 |
Why?
|
Heart Diseases | 2 | 2008 | 492 | 0.030 |
Why?
|
Forced Expiratory Flow Rates | 1 | 2012 | 7 | 0.030 |
Why?
|
Respiratory Mechanics | 1 | 1993 | 75 | 0.030 |
Why?
|
Transcription, Genetic | 3 | 2006 | 1701 | 0.030 |
Why?
|
Fetal Movement | 1 | 1992 | 14 | 0.030 |
Why?
|
Airway Obstruction | 2 | 2011 | 165 | 0.030 |
Why?
|
Nervous System Diseases | 1 | 2017 | 375 | 0.030 |
Why?
|
Tocolytic Agents | 1 | 1992 | 12 | 0.030 |
Why?
|
Mycobacterium tuberculosis | 1 | 2016 | 345 | 0.030 |
Why?
|
Malawi | 1 | 2014 | 396 | 0.020 |
Why?
|
Lactation Disorders | 1 | 1992 | 3 | 0.020 |
Why?
|
Amniotic Fluid | 1 | 1993 | 151 | 0.020 |
Why?
|
Vascular Resistance | 1 | 1993 | 189 | 0.020 |
Why?
|
Hernias, Diaphragmatic, Congenital | 1 | 1997 | 399 | 0.020 |
Why?
|
Parenteral Nutrition, Total | 3 | 1991 | 113 | 0.020 |
Why?
|
Lipoprotein Lipase | 2 | 2003 | 55 | 0.020 |
Why?
|
Diarrhea, Infantile | 2 | 1982 | 35 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2001 | 1547 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2005 | 684 | 0.020 |
Why?
|
Smoking | 2 | 2011 | 1047 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2014 | 897 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2000 | 2048 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 1996 | 531 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 1993 | 227 | 0.020 |
Why?
|
Cell Division | 2 | 2003 | 781 | 0.020 |
Why?
|
Endpoint Determination | 1 | 2011 | 56 | 0.020 |
Why?
|
Prenatal Diagnosis | 1 | 2016 | 596 | 0.020 |
Why?
|
Prenatal Exposure Delayed Effects | 2 | 1985 | 227 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 1997 | 660 | 0.020 |
Why?
|
Behavior | 1 | 2011 | 74 | 0.020 |
Why?
|
Dancing | 1 | 1991 | 9 | 0.020 |
Why?
|
Syndrome | 2 | 2012 | 1119 | 0.020 |
Why?
|
Mesalamine | 1 | 2011 | 6 | 0.020 |
Why?
|
Umbilical Veins | 1 | 1991 | 73 | 0.020 |
Why?
|
Age Distribution | 2 | 2004 | 414 | 0.020 |
Why?
|
Glucose | 2 | 2009 | 879 | 0.020 |
Why?
|
Mice, Inbred C57BL | 3 | 2006 | 4407 | 0.020 |
Why?
|
Housing | 1 | 1991 | 59 | 0.020 |
Why?
|
Mathematics | 3 | 1988 | 97 | 0.020 |
Why?
|
Cricetinae | 2 | 2009 | 422 | 0.020 |
Why?
|
Lymphoproliferative Disorders | 1 | 2012 | 224 | 0.020 |
Why?
|
Urine | 3 | 2003 | 90 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2012 | 665 | 0.020 |
Why?
|
Bronchi | 1 | 2011 | 97 | 0.020 |
Why?
|
Treatment Failure | 1 | 2012 | 335 | 0.020 |
Why?
|
Sheep | 2 | 1988 | 220 | 0.020 |
Why?
|
Failure to Thrive | 1 | 2011 | 90 | 0.020 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 1997 | 612 | 0.020 |
Why?
|
Functional Residual Capacity | 1 | 2010 | 14 | 0.020 |
Why?
|
Ophthalmoscopy | 1 | 2010 | 28 | 0.020 |
Why?
|
Drug Therapy, Combination | 2 | 1998 | 1159 | 0.020 |
Why?
|
Saliva | 3 | 2003 | 114 | 0.020 |
Why?
|
Acute Disease | 2 | 2012 | 1107 | 0.020 |
Why?
|
Endometrium | 1 | 2013 | 281 | 0.020 |
Why?
|
Pulmonary Ventilation | 1 | 2010 | 28 | 0.020 |
Why?
|
Intubation, Intratracheal | 1 | 2013 | 286 | 0.020 |
Why?
|
Activin Receptors, Type II | 1 | 2010 | 31 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 434 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 63 | 0.020 |
Why?
|
Leukocyte Count | 2 | 1988 | 251 | 0.020 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2010 | 36 | 0.020 |
Why?
|
Steroids | 1 | 2011 | 201 | 0.020 |
Why?
|
Kidney | 2 | 2007 | 1367 | 0.020 |
Why?
|
Species Specificity | 2 | 2005 | 549 | 0.020 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 96 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2010 | 285 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 1251 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2011 | 175 | 0.020 |
Why?
|
INDEL Mutation | 1 | 2010 | 87 | 0.020 |
Why?
|
Acute Kidney Injury | 1 | 2017 | 635 | 0.020 |
Why?
|
Models, Anatomic | 1 | 2010 | 99 | 0.020 |
Why?
|
Synkinesis | 1 | 2009 | 2 | 0.020 |
Why?
|
Smiling | 1 | 2009 | 4 | 0.020 |
Why?
|
Sucrase | 1 | 2009 | 22 | 0.020 |
Why?
|
Electrocardiography | 1 | 1995 | 975 | 0.020 |
Why?
|
Facial Asymmetry | 1 | 2009 | 17 | 0.020 |
Why?
|
Pilot Projects | 1 | 2013 | 1396 | 0.020 |
Why?
|
RNA, Messenger | 3 | 2000 | 2821 | 0.020 |
Why?
|
Biogenic Amines | 1 | 1989 | 20 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2010 | 219 | 0.020 |
Why?
|
Muramidase | 3 | 1984 | 94 | 0.020 |
Why?
|
Cognition | 2 | 2012 | 731 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 1260 | 0.020 |
Why?
|
Mesocricetus | 1 | 2009 | 72 | 0.020 |
Why?
|
Persistent Fetal Circulation Syndrome | 1 | 2010 | 89 | 0.020 |
Why?
|
Overweight | 1 | 2012 | 364 | 0.020 |
Why?
|
Nutrition Disorders | 3 | 1987 | 31 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 306 | 0.020 |
Why?
|
Base Sequence | 2 | 2003 | 3101 | 0.020 |
Why?
|
Fibrosis | 1 | 2010 | 435 | 0.020 |
Why?
|
CpG Islands | 1 | 2010 | 324 | 0.020 |
Why?
|
Ammonia | 1 | 1989 | 75 | 0.020 |
Why?
|
Isoantibodies | 1 | 2008 | 72 | 0.020 |
Why?
|
Endorphins | 1 | 1988 | 7 | 0.020 |
Why?
|
Medicaid | 1 | 2011 | 242 | 0.020 |
Why?
|
Disease Progression | 2 | 2009 | 2058 | 0.020 |
Why?
|
Hyperplasia | 1 | 2009 | 208 | 0.020 |
Why?
|
Lactoferrin | 3 | 1984 | 78 | 0.020 |
Why?
|
Neurocognitive Disorders | 1 | 1989 | 67 | 0.020 |
Why?
|
Phosphorus | 2 | 1985 | 56 | 0.020 |
Why?
|
Phenotype | 2 | 2013 | 4258 | 0.020 |
Why?
|
Thermodilution | 1 | 1988 | 11 | 0.020 |
Why?
|
Indicator Dilution Techniques | 1 | 1988 | 25 | 0.020 |
Why?
|
Mice | 4 | 2006 | 17644 | 0.020 |
Why?
|
Bradycardia | 1 | 1988 | 61 | 0.020 |
Why?
|
Coronary Circulation | 1 | 1989 | 215 | 0.020 |
Why?
|
Nitroglycerin | 1 | 1988 | 22 | 0.020 |
Why?
|
Spleen | 1 | 2009 | 279 | 0.020 |
Why?
|
Nitroprusside | 1 | 1988 | 47 | 0.020 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2009 | 190 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2008 | 282 | 0.020 |
Why?
|
Manikins | 1 | 2009 | 135 | 0.020 |
Why?
|
Video Recording | 1 | 2009 | 183 | 0.020 |
Why?
|
Dobutamine | 1 | 1987 | 56 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2010 | 410 | 0.020 |
Why?
|
Aldosterone | 1 | 2007 | 61 | 0.020 |
Why?
|
Body Fluids | 1 | 1988 | 45 | 0.020 |
Why?
|
Endothelin-1 | 1 | 2007 | 40 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 1987 | 248 | 0.020 |
Why?
|
Hypotension | 1 | 2009 | 187 | 0.020 |
Why?
|
Diuresis | 1 | 2007 | 58 | 0.020 |
Why?
|
Renin | 1 | 2007 | 93 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2008 | 231 | 0.020 |
Why?
|
Haemophilus Infections | 1 | 1988 | 90 | 0.020 |
Why?
|
Cultural Characteristics | 1 | 2007 | 41 | 0.020 |
Why?
|
Meningitis | 1 | 1988 | 98 | 0.020 |
Why?
|
Language Development | 1 | 2007 | 33 | 0.020 |
Why?
|
Actuarial Analysis | 2 | 1988 | 34 | 0.020 |
Why?
|
Dinoprost | 1 | 2007 | 28 | 0.020 |
Why?
|
Acidosis | 1 | 1988 | 93 | 0.020 |
Why?
|
Norepinephrine | 1 | 2007 | 177 | 0.020 |
Why?
|
Transcription Factors | 3 | 2003 | 2593 | 0.020 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2007 | 79 | 0.020 |
Why?
|
Data Interpretation, Statistical | 2 | 1998 | 233 | 0.020 |
Why?
|
Sodium | 2 | 1985 | 297 | 0.020 |
Why?
|
Catheterization, Central Venous | 1 | 1988 | 131 | 0.020 |
Why?
|
Postoperative Period | 1 | 2008 | 333 | 0.020 |
Why?
|
Time | 1 | 2007 | 92 | 0.020 |
Why?
|
Trace Elements | 1 | 1987 | 27 | 0.020 |
Why?
|
Defibrillators, Implantable | 1 | 2009 | 190 | 0.020 |
Why?
|
Paresis | 1 | 1986 | 34 | 0.020 |
Why?
|
Waiting Lists | 1 | 2008 | 227 | 0.020 |
Why?
|
vpr Gene Products, Human Immunodeficiency Virus | 1 | 2006 | 13 | 0.020 |
Why?
|
Antigens, Differentiation | 1 | 2006 | 61 | 0.020 |
Why?
|
Non-alcoholic Fatty Liver Disease | 1 | 2011 | 398 | 0.020 |
Why?
|
Electrolytes | 1 | 2006 | 53 | 0.020 |
Why?
|
Anti-Bacterial Agents | 3 | 2004 | 2417 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2010 | 1693 | 0.020 |
Why?
|
Methadone | 2 | 1985 | 126 | 0.020 |
Why?
|
Dopamine | 1 | 1987 | 283 | 0.020 |
Why?
|
Deafness | 1 | 1986 | 82 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2006 | 309 | 0.020 |
Why?
|
Creatine Kinase, MM Form | 1 | 2005 | 5 | 0.020 |
Why?
|
Cineangiography | 1 | 2005 | 17 | 0.020 |
Why?
|
Chemokine CCL11 | 1 | 2005 | 12 | 0.020 |
Why?
|
Contraceptives, Oral, Combined | 1 | 1985 | 14 | 0.020 |
Why?
|
3T3 Cells | 1 | 2005 | 121 | 0.020 |
Why?
|
Heart Ventricles | 2 | 2007 | 769 | 0.020 |
Why?
|
Suction | 1 | 1985 | 54 | 0.020 |
Why?
|
Streptococcus pneumoniae | 2 | 2004 | 375 | 0.020 |
Why?
|
Menstrual Cycle | 1 | 1985 | 34 | 0.020 |
Why?
|
HIV Infections | 2 | 1998 | 1878 | 0.020 |
Why?
|
Home Nursing | 1 | 1985 | 16 | 0.020 |
Why?
|
Magnesium | 1 | 1985 | 123 | 0.020 |
Why?
|
Microspheres | 1 | 2005 | 70 | 0.020 |
Why?
|
Leucovorin | 1 | 2005 | 49 | 0.020 |
Why?
|
Tablets | 1 | 1985 | 28 | 0.020 |
Why?
|
Streptococcal Infections | 1 | 1988 | 243 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 1578 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2006 | 404 | 0.010 |
Why?
|
Folic Acid Deficiency | 1 | 2005 | 53 | 0.010 |
Why?
|
Cytoplasm | 1 | 2006 | 295 | 0.010 |
Why?
|
Oxygen Isotopes | 3 | 1991 | 35 | 0.010 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2005 | 123 | 0.010 |
Why?
|
Graft Survival | 1 | 2007 | 536 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2006 | 6584 | 0.010 |
Why?
|
Chemokine CCL2 | 1 | 2005 | 123 | 0.010 |
Why?
|
Vital Capacity | 1 | 2005 | 76 | 0.010 |
Why?
|
Milk | 1 | 1985 | 119 | 0.010 |
Why?
|
Tricuspid Valve | 1 | 1985 | 60 | 0.010 |
Why?
|
Electron Transport | 1 | 2004 | 55 | 0.010 |
Why?
|
Mucins | 1 | 2005 | 74 | 0.010 |
Why?
|
Placenta | 1 | 2009 | 508 | 0.010 |
Why?
|
Monitoring, Ambulatory | 1 | 2004 | 53 | 0.010 |
Why?
|
Infant Welfare | 1 | 2004 | 28 | 0.010 |
Why?
|
Double Outlet Right Ventricle | 1 | 2004 | 21 | 0.010 |
Why?
|
Short Bowel Syndrome | 1 | 2005 | 65 | 0.010 |
Why?
|
Cattle | 1 | 1985 | 568 | 0.010 |
Why?
|
Blood-Brain Barrier | 1 | 2005 | 143 | 0.010 |
Why?
|
Intelligence | 1 | 1985 | 98 | 0.010 |
Why?
|
Head | 1 | 1985 | 102 | 0.010 |
Why?
|
Interleukin-8 | 1 | 2005 | 209 | 0.010 |
Why?
|
E-Selectin | 1 | 2004 | 41 | 0.010 |
Why?
|
Cell Membrane | 1 | 2006 | 462 | 0.010 |
Why?
|
Breast | 1 | 1985 | 214 | 0.010 |
Why?
|
Polysomnography | 1 | 2005 | 146 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2011 | 880 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2005 | 262 | 0.010 |
Why?
|
Azo Compounds | 1 | 2003 | 8 | 0.010 |
Why?
|
Isomerism | 1 | 2003 | 31 | 0.010 |
Why?
|
Genetic Markers | 1 | 2005 | 603 | 0.010 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2004 | 76 | 0.010 |
Why?
|
Laparotomy | 1 | 2005 | 135 | 0.010 |
Why?
|
Diet, Reducing | 1 | 2004 | 90 | 0.010 |
Why?
|
Anastomosis, Surgical | 1 | 2004 | 173 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2006 | 678 | 0.010 |
Why?
|
Pulmonary Circulation | 1 | 2004 | 121 | 0.010 |
Why?
|
Bicarbonates | 1 | 1983 | 98 | 0.010 |
Why?
|
Phytohemagglutinins | 1 | 2003 | 13 | 0.010 |
Why?
|
Coloring Agents | 1 | 2003 | 77 | 0.010 |
Why?
|
Galactosidases | 1 | 1983 | 7 | 0.010 |
Why?
|
Pulmonary Valve | 1 | 2004 | 92 | 0.010 |
Why?
|
Ligation | 1 | 2003 | 135 | 0.010 |
Why?
|
Interleukin-2 | 1 | 2004 | 244 | 0.010 |
Why?
|
CD4 Antigens | 1 | 2003 | 57 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 1708 | 0.010 |
Why?
|
CD8 Antigens | 1 | 2003 | 41 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 2092 | 0.010 |
Why?
|
Lymphocyte Count | 1 | 2003 | 118 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 822 | 0.010 |
Why?
|
CD3 Complex | 1 | 2003 | 91 | 0.010 |
Why?
|
Diet Surveys | 1 | 1983 | 98 | 0.010 |
Why?
|
Unemployment | 1 | 1982 | 20 | 0.010 |
Why?
|
HIV-1 | 1 | 2006 | 463 | 0.010 |
Why?
|
Antibodies, Viral | 1 | 2009 | 1151 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 2004 | 271 | 0.010 |
Why?
|
Antarctic Regions | 1 | 2002 | 23 | 0.010 |
Why?
|
Ireland | 1 | 2002 | 28 | 0.010 |
Why?
|
Antigens, Neoplasm | 1 | 2005 | 385 | 0.010 |
Why?
|
Patient Dropouts | 1 | 1982 | 52 | 0.010 |
Why?
|
Obstetric Labor, Premature | 1 | 1982 | 85 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2004 | 376 | 0.010 |
Why?
|
Appointments and Schedules | 1 | 2002 | 49 | 0.010 |
Why?
|
L-Selectin | 1 | 2002 | 21 | 0.010 |
Why?
|
RNA | 1 | 2005 | 570 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 1983 | 208 | 0.010 |
Why?
|
Serotyping | 1 | 2002 | 178 | 0.010 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2002 | 54 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2003 | 327 | 0.010 |
Why?
|
Malabsorption Syndromes | 1 | 1982 | 36 | 0.010 |
Why?
|
Interleukin-12 | 1 | 2002 | 115 | 0.010 |
Why?
|
Dermatologic Surgical Procedures | 1 | 2002 | 44 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2002 | 142 | 0.010 |
Why?
|
Pericardiocentesis | 1 | 2001 | 16 | 0.010 |
Why?
|
Educational Status | 1 | 1982 | 276 | 0.010 |
Why?
|
Drug Resistance, Bacterial | 1 | 2004 | 363 | 0.010 |
Why?
|
Microscopy | 1 | 2002 | 119 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2001 | 293 | 0.010 |
Why?
|
Reoperation | 1 | 2004 | 830 | 0.010 |
Why?
|
Pressure | 1 | 2001 | 130 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2002 | 344 | 0.010 |
Why?
|
Solubility | 1 | 2001 | 138 | 0.010 |
Why?
|
Electric Conductivity | 1 | 2000 | 87 | 0.010 |
Why?
|
Drug Utilization | 1 | 1982 | 160 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2006 | 2396 | 0.010 |
Why?
|
Pulmonary Artery | 1 | 2004 | 442 | 0.010 |
Why?
|
Fatty Acid Synthases | 1 | 2000 | 11 | 0.010 |
Why?
|
Glucose Transporter Type 4 | 1 | 2000 | 19 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 1 | 2000 | 13 | 0.010 |
Why?
|
Staphylococcus aureus | 1 | 2004 | 460 | 0.010 |
Why?
|
Ventricular Pressure | 1 | 2000 | 41 | 0.010 |
Why?
|
Homeostasis | 1 | 1985 | 700 | 0.010 |
Why?
|
Sterol Esterase | 1 | 2000 | 19 | 0.010 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 377 | 0.010 |
Why?
|
Intracellular Fluid | 1 | 2000 | 25 | 0.010 |
Why?
|
Deuterium Oxide | 1 | 2000 | 17 | 0.010 |
Why?
|
Antibodies | 1 | 2002 | 375 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2000 | 33 | 0.010 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2000 | 41 | 0.010 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2000 | 28 | 0.010 |
Why?
|
Receptor, Insulin | 1 | 2000 | 67 | 0.010 |
Why?
|
Dactinomycin | 1 | 2000 | 66 | 0.010 |
Why?
|
Diastole | 2 | 1993 | 175 | 0.010 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2000 | 62 | 0.010 |
Why?
|
Opioid-Related Disorders | 1 | 1983 | 260 | 0.010 |
Why?
|
Postprandial Period | 1 | 2000 | 77 | 0.010 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2000 | 74 | 0.010 |
Why?
|
Echocardiography, Transesophageal | 1 | 2001 | 240 | 0.010 |
Why?
|
Electrophysiology | 1 | 2000 | 270 | 0.010 |
Why?
|
Mental Disorders | 1 | 2007 | 823 | 0.010 |
Why?
|
Prosthesis Implantation | 1 | 2001 | 141 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2001 | 1063 | 0.010 |
Why?
|
Drug-Related Side Effects and Adverse Reactions | 1 | 1982 | 257 | 0.010 |
Why?
|
Liver | 1 | 2006 | 1742 | 0.010 |
Why?
|
Ethics, Medical | 1 | 1982 | 395 | 0.010 |
Why?
|
Erythema Multiforme | 1 | 1998 | 2 | 0.010 |
Why?
|
Skin | 1 | 2002 | 519 | 0.010 |
Why?
|
Internship and Residency | 1 | 2009 | 1175 | 0.010 |
Why?
|
Pneumonia, Pneumocystis | 1 | 1998 | 36 | 0.010 |
Why?
|
Hematocrit | 1 | 1998 | 111 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2001 | 688 | 0.010 |
Why?
|
Hydrops Fetalis | 1 | 1998 | 74 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 1983 | 512 | 0.010 |
Why?
|
Cause of Death | 1 | 2000 | 474 | 0.010 |
Why?
|
Adenoviridae | 1 | 2001 | 606 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2001 | 472 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2000 | 794 | 0.010 |
Why?
|
Bilirubin | 1 | 1998 | 122 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2003 | 3891 | 0.010 |
Why?
|
Fetal Blood | 1 | 1998 | 176 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 1998 | 315 | 0.010 |
Why?
|
Myocardial Ischemia | 1 | 2000 | 344 | 0.010 |
Why?
|
Managed Care Programs | 1 | 1997 | 61 | 0.010 |
Why?
|
Hospitals, University | 1 | 1997 | 97 | 0.010 |
Why?
|
Professional Practice Location | 1 | 1996 | 7 | 0.010 |
Why?
|
Neonatology | 1 | 1997 | 53 | 0.010 |
Why?
|
Pedigree | 1 | 2000 | 1604 | 0.010 |
Why?
|
Health Resources | 1 | 1997 | 116 | 0.010 |
Why?
|
Life Tables | 1 | 1995 | 28 | 0.010 |
Why?
|
Evaluation Studies as Topic | 2 | 1988 | 257 | 0.010 |
Why?
|
Hospital Costs | 1 | 1997 | 178 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2000 | 874 | 0.010 |
Why?
|
Carbon Radioisotopes | 1 | 1994 | 71 | 0.010 |
Why?
|
Pneumonia | 1 | 1998 | 322 | 0.010 |
Why?
|
Coronary Disease | 1 | 1998 | 676 | 0.010 |
Why?
|
Health Care Costs | 1 | 1997 | 369 | 0.010 |
Why?
|
Urea | 1 | 1994 | 231 | 0.010 |
Why?
|
Immunoglobulin A, Secretory | 2 | 1984 | 20 | 0.010 |
Why?
|
Syringes | 1 | 1993 | 25 | 0.010 |
Why?
|
Rats, Inbred F344 | 1 | 1993 | 108 | 0.010 |
Why?
|
Zidovudine | 1 | 1993 | 22 | 0.010 |
Why?
|
Down Syndrome | 1 | 1995 | 198 | 0.010 |
Why?
|
Milk Proteins | 2 | 1984 | 92 | 0.010 |
Why?
|
Laser-Doppler Flowmetry | 1 | 1993 | 66 | 0.010 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 1993 | 150 | 0.010 |
Why?
|
Critical Care | 1 | 1998 | 655 | 0.010 |
Why?
|
Systole | 1 | 1993 | 200 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2005 | 1958 | 0.010 |
Why?
|
Crosses, Genetic | 1 | 1992 | 163 | 0.010 |
Why?
|
Pleural Effusion | 1 | 1993 | 100 | 0.010 |
Why?
|
Morbidity | 1 | 1993 | 248 | 0.010 |
Why?
|
Glutathione | 1 | 1993 | 194 | 0.010 |
Why?
|
Clinical Protocols | 1 | 1993 | 237 | 0.010 |
Why?
|
Anorexia Nervosa | 1 | 1991 | 24 | 0.010 |
Why?
|
Fourier Analysis | 1 | 1991 | 59 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2001 | 1660 | 0.010 |
Why?
|
Coronary Vessels | 1 | 1995 | 555 | 0.010 |
Why?
|
Catheters, Indwelling | 1 | 1991 | 154 | 0.010 |
Why?
|
Body Temperature Regulation | 1 | 1990 | 40 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 1993 | 1243 | 0.010 |
Why?
|
Neopterin | 1 | 1989 | 3 | 0.000 |
Why?
|
Dihydropteridine Reductase | 1 | 1989 | 5 | 0.000 |
Why?
|
Emergency Service, Hospital | 2 | 1988 | 1059 | 0.000 |
Why?
|
Sex Chromosome Aberrations | 1 | 1989 | 56 | 0.000 |
Why?
|
Brain Chemistry | 1 | 1989 | 125 | 0.000 |
Why?
|
Hydrochloric Acid | 1 | 1988 | 14 | 0.000 |
Why?
|
Asphyxia Neonatorum | 1 | 1988 | 15 | 0.000 |
Why?
|
Naloxone | 1 | 1988 | 48 | 0.000 |
Why?
|
Neisseria meningitidis | 1 | 1988 | 19 | 0.000 |
Why?
|
Body Fluid Compartments | 1 | 1988 | 19 | 0.000 |
Why?
|
Ultrasonography, Prenatal | 1 | 1993 | 967 | 0.000 |
Why?
|
Plasma | 1 | 1988 | 98 | 0.000 |
Why?
|
Cerebrospinal Fluid Proteins | 1 | 1986 | 23 | 0.000 |
Why?
|
Nutritional Physiological Phenomena | 1 | 1987 | 93 | 0.000 |
Why?
|
Rats | 1 | 1993 | 3728 | 0.000 |
Why?
|
Psychological Tests | 1 | 1986 | 91 | 0.000 |
Why?
|
Follicular Phase | 1 | 1985 | 15 | 0.000 |
Why?
|
Focal Infection | 1 | 1985 | 3 | 0.000 |
Why?
|
Bacterial Infections | 1 | 1988 | 308 | 0.000 |
Why?
|
Ventilators, Mechanical | 1 | 1985 | 34 | 0.000 |
Why?
|
Body Surface Area | 1 | 1985 | 31 | 0.000 |
Why?
|
Cerebral Hemorrhage | 1 | 1986 | 142 | 0.000 |
Why?
|
Cephalometry | 1 | 1985 | 33 | 0.000 |
Why?
|
Hemodynamics | 1 | 1989 | 852 | 0.000 |
Why?
|
Centrifugation | 1 | 1984 | 25 | 0.000 |
Why?
|
Organization and Administration | 1 | 1983 | 4 | 0.000 |
Why?
|
Libraries | 1 | 1983 | 3 | 0.000 |
Why?
|
Quality Control | 1 | 1983 | 120 | 0.000 |
Why?
|
Methods | 1 | 1983 | 149 | 0.000 |
Why?
|
Chromatography, Gas | 1 | 1983 | 30 | 0.000 |
Why?
|
National Institutes of Health (U.S.) | 1 | 1983 | 132 | 0.000 |
Why?
|
Fever | 1 | 1985 | 295 | 0.000 |
Why?
|
Nutritive Value | 1 | 1983 | 91 | 0.000 |
Why?
|
Antigens, Bacterial | 1 | 1984 | 313 | 0.000 |
Why?
|
Zinc | 1 | 1983 | 133 | 0.000 |
Why?
|
Prenatal Care | 1 | 1985 | 347 | 0.000 |
Why?
|
Ambulatory Care | 1 | 1985 | 384 | 0.000 |
Why?
|
Hypothermia | 1 | 1982 | 57 | 0.000 |
Why?
|
Kinetics | 1 | 1983 | 1329 | 0.000 |
Why?
|
History, 20th Century | 1 | 1983 | 380 | 0.000 |
Why?
|
Iron | 1 | 1983 | 270 | 0.000 |
Why?
|